Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making

详细信息    查看全文

• 作者：Alison D. Archibald (2) (3)
  Belinda J. McClaren (1) (2)
  
• 刊名：Journal of Community Genetics
• 出版年：2012
• 出版时间：January 2012
• 年：2012
• 卷：3
• 期：1
• 页码：47-54
• 全文大小：704KB
• 参考文献：1. Abel K, Browner C (1998) Selective compliance with biomedical authority and the uses of experiential knowledge. In: Lock M, Kaufert P (eds) Pragmatic women and body politics. Cambridge University Press, Cambridge, pp 310鈥?26
  2. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, MacSwinney F, Dennis N, Jacobs PA, Syrrou M, Georgiou I, Patsalis PC, Giovannucci U, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B, Vieri F (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study鈥攑reliminary data. Am J Med Genet 83(4):322鈥?25 CrossRef
  3. Archibald AD, Wilfond BS (2006) Population carrier screening: psychological impact. Wiley, New York
  4. Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA (2009) 鈥淚t鈥檚 something I need to consider鈥? decisions about carrier screening for fragile X syndrome in a population of non-pregnant women. Am J Med Genet A 149A(12):2731鈥?738 CrossRef
  5. Barlow-Stewart K, Burnett L, Proos A, Howell V, Huq F, Lazarus R, Aizenberg H (2003) A genetic screening programme for Tay鈥揝achs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 40(4):e45 CrossRef
  6. Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, Marteau T (1993) Uptake of cystic fibrosis testing in primary care: supply push or demand pull? Br Med J 306(6892):1584 CrossRef
  7. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra64 CrossRef
  8. Brookfield SD (1996) Adult learning: an overview. In: Tuijman AC (ed) International encyclopedia of education and training, 2nd edn. Pergamon, Tarrytown
  9. Chen LS, Goodson P (2007) Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genet Med 9(7):442 CrossRef
  10. Christie LM, Zilliacus EM, Ingrey AJ, Turner G (2006) Screening couples for cystic fibrosis carrier status: why are we waiting? Med J Aust 184(9):477
  11. Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell P (1996) Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet 58(3):617
  12. Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S (2005) Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet Med 7(4):246 CrossRef
  13. d鈥橝gincourt-Canning L (2005) The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 14(1):55鈥?9 CrossRef
  14. Delatycki MB (2008) Population screening for reproductive risk for single gene disorders in Australia: now and the future. Twin Res Hum Genet 11(4):422鈥?30 CrossRef
  15. Dodge JA, Lewis PA, Stanton M, Wilsher J (2007) Cystic fibrosis mortality and survival in the UK: 1947鈥?003. Eur Respir J 29(3):522鈥?26 CrossRef
  16. Etchegary H, Potter B, Howley H, Cappelli M, Coyle D, Graham I, Walker M, Wilson B (2008) The influence of experiential knowledge on prenatal screening and testing decisions. Genet Test 12(1):115鈥?24 CrossRef
  17. Gason AA, Metcalfe SA, Delatycki MB, Petrou V, Sheffield E, Bankier A, Aitken M (2005) Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling. Genet Med 7(9):626鈥?32 CrossRef
  18. Godard B, ten Kate L, Evers-Kiebooms G, Ayme S (2003) Population genetic screening programmes: principles, techniques, practices, and policies. Eur J Hum Genet 11(Suppl 2):S49鈥揝87 CrossRef
  19. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57(1):127鈥?30
  20. Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W, Strom CM (2011) FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: Insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet Med 13(1):39 CrossRef
  21. Henneman L, Bramsen I, van Kempen L, van Acker MB, Pals G, van der Horst HE, Ad猫r HJ, van der Ploeg HM, ten Kate LP (2003) Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics 6(1):5鈥?3 CrossRef
  22. Hill MK, Archibald AD, Cohen J, Metcalfe SA (2010) A systematic review of population screening for fragile X syndrome. Genet Med 12(7):396 CrossRef
  23. Hodgson J, Weil J (2011) Talking about disability in prenatal genetic counseling: a report of two interactive workshops. J Genet Couns. doi:10.1007/s10897-011-9410-9 .
  24. Human Genetics Society of Australasia Genetic Services Committee (2009) Cystic fibrosis population screening position paper. Human Genetics Society of Australasia Genetic Services Committee, Alexandria
  25. Ioannou L, Massie J, Collins V, McClaren B, Delatycki MB (2010) Population-based genetic screening for cystic fibrosis: attitudes and outcomes. Public Health Genomics 13(7鈥?):449鈥?56 CrossRef
  26. Janz NK, Becker MH (1984) The health belief model: a decade later. Health Educ Behav 11(1):1 CrossRef
  27. Kolb DA (1984) Experiential learning: experience as the source of learning and development. Prentice Hall, Englewood Cliffs
  28. Lippman A (1999) Embodied knowledge and making sense of prenatal diagnosis. J Genet Couns 8(5):255鈥?73 CrossRef
  29. Massie J, Forbes R, Dusart D, Bankier A, Delatycki MB (2007) Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. J Paediatr Child Health 43(11):721鈥?23 CrossRef
  30. Massie J, Petrou V, Forbes R, Curnow L, Ioannou L, Dusart D, Bankier A, Delatycki M (2009) Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience. Aust N Z J Obstet Gynaecol 49(5):484鈥?89 CrossRef
  31. McClaren BJ, Delatycki MB, Collins V, Metcalfe SA, Aitken M (2008) 鈥業t is not in my world鈥? an exploration of attitudes and influences associated with cystic fibrosis carrier screening. Eur J Hum Genet 16(4):435鈥?44 CrossRef
  32. McConkie-Rosell A, Finucane B, Cronister A, Abrams L, Bennett RL, Pettersen BJ (2005) Genetic counseling for fragile X syndrome: updated recommendations of the national society of genetic counselors. J Genet Couns 14(4):249鈥?70 CrossRef
  33. Metcalfe S, Barlow-Stewart K, Delatycki MB, Emery JD (2007) Population genetic screening. Aust Fam Physician 36(10):794鈥?00
  34. Metcalfe S, Jaques A, Archibald A, Burgess T, Collins V, Henry A, McNamee K, Sheffield L, Slater H, Wake S, Cohen J (2008) A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med 10(7):525鈥?35 CrossRef
  35. Metcalfe SA, Bittles AH, O鈥橪eary P, Emery J (2009) Australia: public health genomics. Public Health Genomics 12(2):121鈥?28 CrossRef
  36. National Institutes of Health (1999) Consensus development conference statement on genetic testing for cystic fibrosis. Arch Intern Med 159(14):1529鈥?539 CrossRef
  37. O鈥橲ullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 373(9678):1891鈥?904 CrossRef
  38. Plass AMC, van El CG, Pieters T, Cornel MC (2010) Neonatal screening for treatable and untreatable disorders: prospective parents鈥?opinions. Pediatrics 125(1):e99 CrossRef
  39. Sheeran P, Abraham C (1995) The health belief model. In: Conner M, Norman P (eds) Predicting health behaviour. Open University Press, Buckingham, pp 23鈥?1
  40. Sherman S, Pletcher BA, Driscoll DA (2005) Fragile X syndrome: diagnostic and carrier testing. Genet Med 7(8):584鈥?87 CrossRef
  41. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C (2007) A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 6(1):57鈥?5 CrossRef
  42. Tercyak KP, Johnson SB, Roberts SF, Cruz AC (2001) Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns 43(1):73鈥?4 CrossRef
  43. van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G (2006) Informed decision making in the context of prenatal screening. Patient Education and Counseling 63(1鈥?):110鈥?17 CrossRef
  44. Ziebland S, Herxheimer A (2008) How patients鈥?experiences contribute to decision making: illustrations from DIPEx (personal experiences of health and illness). J Nurs Manag 16(4):433鈥?39 CrossRef
  
• 作者单位：Alison D. Archibald (2) (3)
  Belinda J. McClaren (1) (2)
  
  2. Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia
  3. Royal Children鈥檚 Hospital, Genetics Education and Health Research, Murdoch Childrens Research Institute, Flemington Rd, Melbourne, Victoria, Australia
  1. Genetics Education and Health Research Royal Childrens Hospital, Murdoch Childrens Research Institute, Flemington Rd, Melbourne, Victoria, Australia
  

文摘